Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Acyclovir sodium
Drug ID BADD_D00040
Description Acyclovir is a nucleotide analog antiviral used to treat herpes simplex, _Varicella zoster_, herpes zoster, herpes labialis, and acute herpetic keratitis[L7303,L7315,L7318,L7321,L7324,L7327]. Acyclovir is generally used first line in the treatment of these viruses and some products are indicated for patients as young as 6 years old.[L7321] Acyclovir was granted FDA approval on 29 March 1982.[L7318]
Indications and Usage For the treatment and management of herpes zoster (shingles), genital herpes, and chickenpox.
Marketing Status Prescription; Discontinued
ATC Code D06BB03; J05AB01; S01AD03
DrugBank ID DB00787
KEGG ID D02764
MeSH ID D000212
PubChem ID 23665721
TTD Drug ID D0B5MP
NDC Product Code 63323-325; 55150-155; 46014-1019; 55150-154; 14335-150
Synonyms Acyclovir | 9-((2-Hydroxyethoxy)methyl)guanine | Aciclovir | Acycloguanosine | Herpoviric | Aciclobeta | Aciclostad | Isavir | Laciken | Mapox | Maynar | Milavir | Opthavir | Supraviran | Viclovir | Vipral | Virax-Puren | Virax Puren | ViraxPuren | Virherpes | Virmen | Virolex | Virupos | Virzin | Wellcome-248U | Wellcome 248U | Wellcome248U | Zoliparin | Zovirax | Zyclir | Aciclovir Alonga | Alonga, Aciclovir | Acifur | Acipen Solutab | Solutab, Acipen | Acivir | Activir | Acyclo-V | Acyclo V | Acyclovir Sodium | Sodium, Acyclovir | Antiherpes Creme | aciclovir von ct | Avirax | Cicloferon | Clonorax | Cusiviral | Genvir | Herpetad | Herpofug | Herpotern | Aci-Sanorania | Aci Sanorania | Aciclovir-Sanorania | Aciclovir Sanorania | Acic
Chemical Information
Molecular Formula C8H10N5NaO3
CAS Registry Number 69657-51-8
SMILES C1=NC2=C(N1COCCO)N=C(N=C2[O-])N.[Na+]
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Neurological symptomMyelin basic proteinP02686T54761Not Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Hypotension24.06.03.002--
Jaundice09.01.01.004; 01.06.04.004; 23.03.03.030--Not Available
Leukocytosis01.02.01.002--
Leukopenia01.02.02.001--Not Available
Lymphadenopathy01.09.01.002--Not Available
Myalgia15.05.02.001--
Nausea07.01.07.001--
Necrosis24.04.02.006; 08.03.03.001--Not Available
Neutropenia01.02.03.004--Not Available
Neutrophilia01.02.01.005--Not Available
Oedema peripheral08.01.07.007; 14.05.06.011; 02.05.04.007--
Pain08.01.08.004--
Paraesthesia17.02.06.005--
Phlebitis24.05.03.001; 12.02.01.002--
Photosensitivity reaction23.03.09.003--
Pruritus23.03.12.001--
Pyrexia08.05.02.003--
Rash23.03.13.001--Not Available
Renal failure20.01.03.005--Not Available
Seizure17.12.03.001--
Somnolence19.02.05.003; 17.02.04.006--
Stevens-Johnson syndrome10.01.03.020; 23.03.01.007; 12.03.01.014; 11.07.01.005--
Thrombocytopenia01.08.01.002--Not Available
Thrombocytosis01.08.02.001--Not Available
Toxic epidermal necrolysis12.03.01.015; 11.07.01.006; 10.01.01.006; 23.03.01.008--
Tremor17.01.06.002--
Urticaria23.04.02.001; 10.01.06.001--
Visual impairment06.02.06.008--Not Available
Vomiting07.01.07.003--
Transaminases increased13.03.01.015--Not Available
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages